Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Improving Seniors’ Timely Access to Care Act of 2019
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Improving Seniors’ Timely Access to Care Act of 2019
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2021 · fourth_quarter · Q4
US-China Trade Issues-volume-based procurement; US-Japan Trade Issues- 2022 Japan med tech price revision;
Patient access to ambulatory surgery centers; Addressing health disparities, Medicare Outpatient Surgery and Quality Access Act
Source: Senate LDA
Improving Seniors’ Timely Access to Care Act of 2019
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Medical Device tax Repeal (S. 692), Corporate Tax, health provider funding
Medical Device tax Repeal (S. 692), FDARA Implementation
Medical Device tax Repeal (S. 692), Corporate Tax
Tax Reform Technical Corrections, Medical Device Tax Repeal (S.692)
Medical Device tax Repeal (S. 692), FDARA Implementation
Medical Device tax Repeal (S. 692), FDARA Implementation
To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments for granting export certifications.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments for granting export certifications.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
Protect Medical Innovation Act of 2013
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Medical Device Tax Repeal (HR 523 and S 232)
Medical Device Access and Innovation Protection Act
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Medical Device Tax Repeal (HR 523 and S 232)
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Med Device Tax Repeal H.R. 436 S.17
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Medical device tax repeal - HR 436
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 and corporate tax reform
medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 and corporate tax reform
Russian World Trade Organization Commitments Verification Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Russia PNTR HR 6149, HR 6156, S.3327, S.3406
Russia and Moldova Jackson-Vanik Repeal and Sergei Magnitsky Rule of Law Accountability Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Russia PNTR HR 6149, HR 6156, S.3327, S.3406
Build America Bonds Extension for Rural and Urban Transportation and Highways Act of 2011
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 and corporate tax reform
Premarket Predictability Act of 2011
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 17, H.R. 436 - Medical Device Tax Repeal H.R. 3209, 3203, 3230, 3205, 3211, 3208, 3206, 3214, 3207, 3204 and S. 1700, 1865, 1943, 1972, 1995 - FDA Policy Physician-owned Distributors
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
PL 111-148 Implementation and Medical Device Tax Repeal (S 17, S 262, HR 436, HR 488, HR 736)
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 Corporate tax reform
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
PL 111-148 implementation and medical device tax repeal (s17, s262, HR 436, HR 488, HR 736)
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 17, H.R. 436 - Medical Device Tax Repeal H.R. 3209, 3203, 3230, 3205, 3211, 3208, 3206, 3214, 3207, 3204 and S. 1700, 1865, 1943, 1972, 1995 - FDA Policy Physician-owned Distributors
Medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 Corporate tax reform
PL 111-148 implementation and medical device tax repeal (s17, s262, HR 436, HR 488, HR 736)
PL 111-148 Implementation and Medical Device Tax Repeal (S 17, S 262, HR 436, HR 488, HR 736)
Build America Bonds Extension for Rural and Urban Transportation and Highways Act of 2011
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 Corporate tax reform
Build America Bonds Extension for Rural and Urban Transportation and Highways Act of 2011
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
PL 111-148 Implementation and Medical Device Tax Repeal (S 17, S 262, HR 436, HR 488, HR 736)
Build America Bonds Extension for Rural and Urban Transportation and Highways Act of 2011
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
PL 111-148 implementation and medical device tax repeal (s17, s262, HR 436, HR 488, HR 736)
To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Patent reform legislation S 515, Patent false marking (HR 4954)
Patent reform legislation S 515, Patent false marking (HR 4954)
Patent Reform - S.515 Manager's Amendment
American Middle Class Tax (AMT) Relief Act of 2007
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Health Care Reform bills, specifically HR 3590 and Health Care and Education Affordability Reconciliation Act
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Tax deferral, R&D credit, House and Senate Budget Resolutions (H. Con. Res 85 and S. Con Res. 13)
National Knee and Hip Replacement Registry Act of 2009
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
National Joint Registry (HR 2813), FDA 510(k) issues, H Res 577 (Orthopedic Resolution) Various health care reform draft bills from the House Tri-Committees and Senate HELP and Finance Committees
Recognizing the Nation's orthopedic industry for its continued legacy of innovation in providing devices that relieve the pain of, and restore mobility to, active duty armed service members, veterans, and patients of all ages from all walks of life.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
National Joint Registry (HR 2813), FDA 510(k) issues, H Res 577 (Orthopedic Resolution) Various health care reform draft bills from the House Tri-Committees and Senate HELP and Finance Committees
To amend the Internal Revenue Code of 1986 to prevent corporations from exploiting tax treaties to evade taxation of United States income.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
Food and Drug Administration Amendments Act of 2007
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
Physician Payments Sunshine Act of 2008
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2029 (Physician Payment Sunshine Act) S. 2221 (Medical Device Price Transparency Act) H.R. 5605 (Physician Payment Sunshine Act)
Physician Payments Sunshine Act of 2008
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2029 and H.R. 5605 (Physician Payment Sunshine Act) Proposed FY09 Rule for Medicare Inpatient Prospective Payment System
Physician Payments Sunshine Act of 2008
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2029 and H.R. 5605 Physician Payment Sunshine Act Medicare CY09 Physician Fee Schedule Proposed Rule S.3408 Comparative Effectiveness Research Act of 2008
Responsibility in Drug and Device Advertising Act of 2008
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
Physician Payments Sunshine Act of 2007
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2029 and H.R. 5605 (Physician Payment Sunshine Act) Proposed FY09 Rule for Medicare Inpatient Prospective Payment System
Physician Payments Sunshine Act of 2007
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2029 (Physician Payment Sunshine Act) S. 2221 (Medical Device Price Transparency Act) H.R. 5605 (Physician Payment Sunshine Act)
Physician Payments Sunshine Act of 2007
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2029 and H.R. 5605 Physician Payment Sunshine Act Medicare CY09 Physician Fee Schedule Proposed Rule S.3408 Comparative Effectiveness Research Act of 2008
Transparency in Medical Device Pricing Act of 2007
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2029 (Physician Payment Sunshine Act) S. 2221 (Medical Device Price Transparency Act) H.R. 5605 (Physician Payment Sunshine Act)
R&D Tax Credit/CFC Look Thru (tax extenders legislation, H.R. 1424, S.334)
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
Comparative Effectiveness Research Act of 2008
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2029 and H.R. 5605 Physician Payment Sunshine Act Medicare CY09 Physician Fee Schedule Proposed Rule S.3408 Comparative Effectiveness Research Act of 2008
American Samoa Possession Tax Credit Act of 2003
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
R&D Tax Credit/CFC Look Thru (tax extenders legislation, H.R. 1424, S.334)
Physician Payments Sunshine Act of 2007
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2221 (Medical Device Price Transparency Act) S. 2029 (Physician Payment Sunshine Act) and House companion bill introduced by Rep. DeFazio Direct to Consumer Advertising Legislation considered by Rep. DeRosa pertaining to drugs and devices
Transparency in Medical Device Pricing Act of 2007
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2221 (Medical Device Price Transparency Act) S. 2029 (Physician Payment Sunshine Act) and House companion bill introduced by Rep. DeFazio Direct to Consumer Advertising Legislation considered by Rep. DeRosa pertaining to drugs and devices
Corporate Tax Legislation-(Build Back Better legislation; TCJA; international tax changes
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2021 · third_quarter · Q3
US-China Trade Issues; US-Japan Trade Issues;
Corporate Tax Legislation; TCJA; international tax changes
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2021 · second_quarter · Q2
Corporate Tax Legislation; Tax Cuts and Jobs Act changes; Internal tax changes
US-China Trade Issues; US-Japan Trade Issues;
FDA CFG Authentication Issue; Processing delay at US State Department; Equitable access to medical technology; Device shortage reporting requirements
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2021 · first_quarter · Q1
US-China Trade Issues
FDA CFG Authentication Issue; Processing delay at US State Department
Corporate Tax Legislation; Tax Cuts and Jobs Act changes; Internal Revenue Code Section 163j
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · second_quarter · 2A
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
CARES Act
US-China Phase 1 Trade Deal implementation
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · fourth_quarter · Q4
Medicare and Corporate Tax provisions
implementation of Administration Executive Orders related to China sanctions
Year-end COVID Relief and FY21 Omnibus Spending bills; COVID vaccine allocation and funding
Filing targets: HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · second_quarter · 2A
US-China Phase 1 Trade Deal implementation
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
CARES Act
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · third_quarter · Q3
US-China Phase 1 Trade Deal implementation; US-India trade deal
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · second_quarter · Q2
US-China Phase 1 Trade Deal implementation
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
CARES Act
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · first_quarter · Q1
Medical Device tax Repeal (S. 692), Corporate Tax, health provider funding
US-EU Trade Issues(EU MDR implementation), US-Japan trade issues
CARES Act, Device shortage reporting during a public health emergency, Paycheck Protection Act,
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2019 · fourth_quarter · Q4
Medical Device Tax Repeal, Corporate Tax
Medical Device tax Repeal (S. 692), Corporate Tax
US-EU Trade Issues, US-Japan trade talks
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2019 · third_quarter · Q3
US-EU Trade Issues, US-Japan trade talks, US-India GSP, Internal Revenue Trade
Medical Device tax Repeal (S. 692), FDARA Implementation
Medical Device Tax Repeal, India device price controls, Diagnostic payment Reform
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2019 · third_quarter · RA
MDET repeal, FDA Regulations, VA Procurement
MDET repeal, FDA Regulations, VA Procurement
MDET repeal, FDA Regulations, VA Procurement
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2019 · second_quarter · Q2
US-EU Trade Issues, US-Japan trade talks, US-India GSP, Internal Revenue Trade
Medical Device Tax Repeal, India device price controls, Diagnostic payment Reform
Medical Device tax Repeal (S. 692), FDARA Implementation
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2019 · first_quarter · Q1
Tax Reform Technical Corrections, Medical Device Tax Repeal (S.692)
US-EU trade issues, US-Japan Trade talks, US-India GSP
Medical Device tax Repeal (S. 692), FDARA Implementation
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2019 · first_quarter · RA
MDET repeal, FDA Regulations, VA Procurement
MDET repeal, FDA Regulations, VA Procurement
MDET repeal, FDA Regulations, VA Procurement
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2018 · fourth_quarter · Q4
MDET repeal, technical corrections to TCJA
Proposed 301 tariffs on China imports and 232 tariffs
MDET repeal, FDARA implementation
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2018 · third_quarter · Q3
MDET repeal, tax reform
MDET repeal, VA Procurement, FDARA implementation, Sunshine Open Payments
Proposed 301 tariffs on China imports and 232 tariffs
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2018 · second_quarter · Q2
Proposed 301 tariffs on China imports
MDET repeal, tax reform
MDET repeal, VA Procurement, FDARA implementation, Sunshine Open Payments
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2018 · first_quarter · Q1
MDET repeal in January CR spending bill
MDET repeal, tax reform
Mexico procurement, India price controls, potential 301 tariffs on China imports
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2017 · fourth_quarter · Q4
MDET repeal, tax reform
Mexico procurement, India price controls
MDET repeal
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2017 · third_quarter · Q3
MDET repeal, tax reform
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
NAFTA Renegotiation, India price controls
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2017 · second_quarter · Q2
NAFTA Renegotiation, India price controls
MDET repeal, tax reform
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2017 · first_quarter · Q1
MDUFA Reauthorization, FDA Inspections, MDET repeal
NAFTA Renegotiation, India price controls
MDET repeal, tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2016 · fourth_quarter · Q4
FDA User Fee Reauthorization; FDA re-processing regulations, FDA facility inspection process reforms
MDET Repeal; Corporate Tax Reform
TPP and General Trade Policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2016 · third_quarter · Q3
Medicare Inpatient, Outpatient and Physician Payment Rules; FDA re-processing regulations, FDA facility inspections
MDET Repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2016 · second_quarter · 2A
Corporate Tax Reform, MDET Repeal
TPP
Energy and Commerce Committee's 21st Century Cures; Medicare payment (CCJR and proposed Medicare Inpatient Payment and Physician Payment Rules); FDA inspections; FY17 Ag Appropriations; MDUFA Reauthorization; FDA re-processing regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2016 · second_quarter · Q2
Energy and Commerce Committee's 21st Century Cures; Medicare payment (CCJR and proposed Medicare Inpatient Payment and Physician Payment Rules); FDA inspections; FY17 Ag Appropriations; MDUFA Reauthorization; FDA re-processing regulations
Corporate Tax Reform, MDET Repeal
TPP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2016 · first_quarter · Q1
TPP
Energy and Commerce Committee's 21st Century Cures; Medicare payment (CCJR); FDA inspections; FY17 Ag Appropriations; MDUFA Reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2015 · fourth_quarter · Q4
Energy and Commerce Committee's 21st Century Cures; VA Healthcare Vendor Credentialing; Medicare payment (CCJR); Device Distributor Licensing
Corporate Tax Reform; Medical Device Excise Tax Repeal
TPP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2015 · third_quarter · Q3
TPA/TPP
Energy and Commerce Committee's 21st Century Cures; VA Healthcare Vendor Credentialing; FDA reform; Medicare payment (CCJR)
Corporate Tax Reform; Medical Device Excise Tax Repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2015 · second_quarter · Q2
Corporate Tax Reform; Medical Device Excise Tax Repeal
Energy and Commerce Committee's 21st Century Cures
TPA/TPP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2015 · first_quarter · Q1
FDA Sequestration; Energy and Commerce Committee's 21st Century Cures; Medicare Payment Reforms (Bundled Payment/Gainsharing)
TPA/TPP
Corporate Tax Reform; Medical Device Excise Tax Repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2014 · fourth_quarter · Q4
TRADE - Transpacific Partnership FTA including Transparency and Procedural Fairness Annex for Medical Devices
TAX - Medical Device Excise Tax Repeal Bills House and Senate; Corporate Tax Extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2014 · third_quarter · Q3
Tax Reform and Tax Extenders
Trans-Pacific Partnership Agreement
Medical Device Excise Tax; Implementation of the Food and Drug Administration Safety and Innovation Act; Energy & Commerce Committee's 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2014 · second_quarter · Q2
Tax reform
TPP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2014 · first_quarter · Q1
TPP/TPA
Tax reform and Tax Extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2013 · fourth_quarter · Q4
Medical Device Tax Repeal (HR 523 and S 232)
TPP, TPA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2013 · third_quarter · Q3
Medicare payment (ACO/bundled payments/Physician Payment Proposed rule)
TPP/Japan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2013 · second_quarter · Q2
Japan entry into TPP
FDA UDI Rule; FDA user fee/sequestration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2013 · first_quarter · Q1
Korea FTA Implementation
Corporate Tax Reform
Medical Device Repeal; Implementation of the Food and Drug Administration Safety and Innovation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2012 · fourth_quarter · Q4
Russia PNTR
Medical Device Tax Repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2012 · third_quarter · Q3
Med Device Tax Repeal H.R. 436 S.17
Russia PNTR HR 6149, HR 6156, S.3327, S.3406
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2012 · second_quarter · Q2
Medical device user fee reauthorization legislation - FDA Safety and Innovation Act, including custom device provision of the act
Medical device tax repeal - HR 436
Russia PNTR legislation
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2012 · first_quarter · Q1
FDA medical device user fee reauthorization, custom device issues and reprocessing of single use devices, and musculoskeletal health disparities congressional resolution
medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 and corporate tax reform
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2011 · fourth_quarter · Q4
Japan and China reimbursement and regualtory industry issues
S. 17, H.R. 436 - Medical Device Tax Repeal H.R. 3209, 3203, 3230, 3205, 3211, 3208, 3206, 3214, 3207, 3204 and S. 1700, 1865, 1943, 1972, 1995 - FDA Policy Physician-owned Distributors
Corporate Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2011 · third_quarter · Q3
FDA 510k reform and Medical Device User Fees and PPACA (health care law) implementation and Musculoskeletal Health Disparties Summit in D.C.
Medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 Corporate tax reform
KORUS FTA
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2011 · second_quarter · Q2
physician owned distributors in medicare - Senate Finance Committee work on the topic
PL 111-148 implementation and medical device tax repeal (s17, s262, HR 436, HR 488, HR 736)
HR 1249 and S 23 regarding patent reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2011 · first_quarter · Q1
Patent Reform, HR 1249 and S 23
Corporate Tax Reform
PL 111-148 Implementation and Medical Device Tax Repeal (S 17, S 262, HR 436, HR 488, HR 736)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2010 · fourth_quarter · Q4
China Currency and Medical Device Policy
FDA Reform, PPACA implementation (CER, Sunshine), Gainsharing
Medical Device Research Funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2010 · third_quarter · Q3
FDA 510(k) Reform, Implementation of Sunshine provision of PPACA health care reform law, Implementation of Comparative Effectiveness Research provision of PPACA health care reform law, GAO study on implantable medical device pricing matters, Sen Grassley inquiry of Zimmer based on NY Time article re orthopedic surgeons
Defense appropriations for Zimmer's fracture nail gun (medical device technology for military application) - Senate Dept of Defense Appropriations bill
Patent reform legislation S 515, Patent false marking (HR 4954)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2010 · second_quarter · Q2
Patent Reform - S.515 Manager's Amendment
Trade (Turkey medical device regulations)
Healthcare Reform (The Patient Protection and Affordable Care Act (PPACA) (Pub.L. 111-148)) FDA reform issues
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2010 · first_quarter · Q1
Seeking federal earmark funding for trauma-related medical device project with military application; worked on strategies related to House and Senate appropriations for Defense
Brazil-US trade dispute over cotton, with possible Brazilian retaliatory tariffs on orthopedic implant imports
Health Care Reform bills, specifically HR 3590 and Health Care and Education Affordability Reconciliation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2009 · fourth_quarter · Q4
China price control policy issue and Japan price revision policy
International tax reform related issues like deferral plus corporate tax related issues like tax extenders
FDA policy issues especially potential 510k review policy changes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2009 · third_quarter · Q3
International corporate tax reform and Over the Counter financial derivatives issues
FDA issues including 510k process for medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2009 · second_quarter · Q2
National Joint Registry (HR 2813), FDA 510(k) issues, H Res 577 (Orthopedic Resolution) Various health care reform draft bills from the House Tri-Committees and Senate HELP and Finance Committees
Physician Payment Disclosure (Sunshine) bill - cosponsors Sens. Grassley and Kohl Medicare Proposed Inpatient Prospective Payment System Rule for FY10
Patent Reform Bills in the House and Senate
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2009 · first_quarter · Q1
National Joint Registry, 510(k) process with emphasis on Class III 510(k) devices per GAO Report, Reprocessing single use medical devices Physician Payment Sunshine Legislation (co-sponsored by Senators Kohl and Grassley)
Tax deferral, R&D credit, House and Senate Budget Resolutions (H. Con. Res 85 and S. Con Res. 13)
Gainsharing exception through Stark Law
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2008 · fourth_quarter · Q4
Medicare Inpatient Coding (ICD-10) Issue Medicare CY09 Final Physician Fee Schedule Rule - Gainsharing provision
R&D Tax Credit/CFC Look Thru (tax extenders legislation, H.R. 1424, S.334)
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2008 · third_quarter · Q3
S. 2029 and H.R. 5605 Physician Payment Sunshine Act Medicare CY09 Physician Fee Schedule Proposed Rule S.3408 Comparative Effectiveness Research Act of 2008
Import Safety Legislation (draft discussion bills in House [Rep Dingell] and Senate) Medical Device Safety Act - medical device federal preemption bill Direct-to-Consumer Advertising legislative discussions and Senate Aging Committee hearing FDA Post-Market Surveillance issues/proposals in the area of medical devices
Extension of R&D Tax Credit and CFC Look Thru Provision - separately (H.R. 6049) and as part of the Financial Bailout Bill
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2008 · second_quarter · Q2
Korea price cuts for medical devices China re-registration and price controls
Import Safety Legislation (draft) Federal Preemption for Medical Devices Direct to Consumer Advertising Legislation (proposed)
Tax Extenders Bill (H.R. 6049)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2008 · first_quarter · Q1
Extension of the Research & Experimentation Tax Credit
S. 2029 (Physician Payment Sunshine Act) S. 2221 (Medical Device Price Transparency Act) H.R. 5605 (Physician Payment Sunshine Act)
Japan reimbursement price policy revisions for medical devices - This included monitoring Congressional and Administration activity related to Japan trade, keeping staff of Congressional offices and Department of Commerce and USTR updated on in country developments and securing Congressional letter to Japan officials on reimbursement pricing policy revisions
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2007 · year_end · YY
S. 2221 (Medical Device Price Transparency Act) S. 2029 (Physician Payment Sunshine Act) and House companion bill introduced by Rep. DeFazio Direct to Consumer Advertising Legislation considered by Rep. DeRosa pertaining to drugs and devices
Monitoring Congressional trade activities related to Korea, China and Japan, and lobbying the Executive and Legislative Branches on support for medical device regulatory and reimbursement policy related issues in those markets
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2007 · mid_year · MM
Monitoring and lobbying general Congressional and Administration activities on trade issues, particularly the US-KOREA FTA and China currency/trade
FDA bills, especially S1082 and H2900, regarding the medical device user fee program and other FDA issues related to medical devices
FY08 Proposed Medicare Inpatient Prospective Payment System Rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2006 · year_end · YY
Tax Relief and Health Care Act of 2006 - R&D Tax Credit
Section 646 of Medicare Modernization Act - Gainsharing Demonstration Projects Medicare FY07 Hospital Inpatient Prospective Payment System Interim and Final Rules
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2006 · mid_year · MM
Medicare Hospital Inpatient Rule FY07 (Proposed and Final Rules), HIT Bill (HR4157), Gainsharing Provisions in 2006 Deficit Reduction Act, R&D Tax Credit, and Trade Issues Related to Japan and China
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. International Trade Commission (ITC)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2005 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2005 · mid_year · RR
Medical Device Tax Repeal, Corporate Tax
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
MDET repeal, FDA Regulations, VA Procurement
MDET repeal, FDA Regulations, VA Procurement
Patent reform, HR 1249 and S 23
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
International tax reform issues as discussed in context of health care reform proposals - CFC look thru, deferral, check the box, etc.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Medical device trade-related issues (regulatory, reimbursement) with Japan and China
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
S. 2029 and H.R. 5605 (Physician Payment Sunshine Act) Proposed FY09 Rule for Medicare Inpatient Prospective Payment System
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)